Showing results (21-30 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Experimental Medicine|April 3, 2019
Bloom syndrome protein restrains innate immune sensing of micronuclei by cGASMatthieu Gratia, Mathieu P Rodero, Cécile Conrad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 14, 2020
From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory MyopathiesCyrielle Hou, Chloé Durrleman, Baptiste Periou, et al.
Cardiovascular Research|May 27, 2010
Regulation of monocyte subset systemic levels by distinct chemokine receptors controls post-ischaemic neovascularizationClément Cochain, Mathieu P Rodero, José Vilar, et al.
Neuropediatrics|November 29, 2019
Biallelic Mutations in MTPAP Associated with a Lethal EncephalopathyLien Van Eyck, Francesco Bruni, Anne Ronan, et al.
Cell Reports. Medicine|September 1, 2021
Compromised mitochondrial quality control triggers lipin1-related rhabdomyolysisYamina Hamel, François-Xavier Mauvais, Marine Madrange, et al.
Rheumatology (Oxford, England)|February 12, 2021
JAK inhibitors are effective in a subset of patients with juvenile dermatomyositis: a monocentric retrospective studyTom Le Voyer, Cyril Gitiaux, François-Jérôme Authier, et al.
Frontiers in Immunology|October 12, 2023
Targeting the chemokine receptor CXCR4 with histamine analog to reduce inflammation in juvenile arthritisNassima Bekaddour, Nikaïa Smith, Benoit Beitz, et al.
Rheumatology (Oxford, England)|May 24, 2025
Myositis-specific autoantibody subtypes are associated with response to Janus kinase inhibitors in patients with juvenile dermatomyositisBrigitte Bader-Meunier, Thomas R J Moreau, Florence Aeschlimann, et al.
Brain : a Journal of Neurology|May 10, 2018
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositisLeandro Ladislau, Xavier Suárez-Calvet, Ségolène Toquet, et al.
Science Advances|July 17, 2019
Control of TLR7-mediated type I IFN signaling in pDCs through CXCR4 engagement-A new target for lupus treatmentNikaïa Smith, Mathieu P Rodero, Nassima Bekaddour, et al.
Pageof 5